· Additional content on practical prescribing and polypharmacy· Coverage of all major therapeutic topics by body system.· Introductory sections give brief chapter synopses.· Case studies where relevant.· Covers the needs of the developing world with a focus on practical prescribing and health technology assessment.· Definition, tips, brief explanation boxes throughout.· Interesting histories, etymologies and provenances of terms throughout.· Entertaining footnotes throughout.
Bringing in a new junior editor (a Clinical Pharmacologist) to assist as Morris Brown will not be as available as he has been in past editions.Adding in more practical prescribing information to widen the market to non-medical prescribers.Add in Polypharmacy as being added to the examsIE – Competency Mapping will be included in the IE FM for India markets (£1000 added to the manuscript development budget to cover this)
1. Clinical Pharmacology - p. c 2. Cover image - p. c 3. Quotes - p. ii 4. Title page - p. iii 5. Copyright - p. iv 6. Table of Contents - p. v 7. Preface - p. vii 8. Contributors - p. ix 9. Acknowledgements - p. xiii 10. Section 1 General - p. 1 11. Chapter 1 Clinical pharmacology - p. 2 12. Chapter 2 Topics in drug therapy - p. 5 13. Chapter 3 Discovery and development of drugs - p. 27 14. Chapter 4 Evaluation of drugs in humans - p. 36 15. Chapter 5 Health technology assessment for pharmaceutical products - p. 47 16. Chapter 6 Regulation of medicines - p. 54 17. Chapter 7 Classification and naming of drugs - p. 64 18. Chapter 8 Polypharmacy and medicines optimisation - p. 68 19. Section 2 From pharmacology to toxicology - p. 90 20. Chapter 9 General pharmacology - p. 91 21. Chapter 10 Unwanted effects and adverse drug reactions - p. 126 22. Chapter 11 Poisoning, overdose, antidotes - p. 139 23. Chapter 12 Drug dependence - p. 155 24. Section 3 Infection and inflammation - p. 180 25. Chapter 13 Chemotherapy of infections - p. 181 26. Chapter 14 Antibacterial drugs - p. 193 27. Chapter 15 Chemotherapy of bacterial infections - p. 213 28. Chapter 16 Viral, fungal, protozoal and helminthic infections - p. 236 29. Chapter 17 Therapeutics for COVID-19 - p. 266 30. Chapter 18 Drugs for inflammation and joint disease - p. 273 31. Chapter 19 Drugs and the skin - p. 296 32. Section 4 Nervous system - p. 313 33. Chapter 20 Pain and analgesics - p. 314 34. Chapter 21 Anaesthesia and neuromuscular block - p. 337 35. Chapter 22 Psychotropic drugs - p. 353 36. Chapter 23 Neurological disorders – epilepsy, Parkinson’s disease and multiple sclerosis - p. 396 37. Section 5 Cardiorespiratory and renal systems - p. 424 38. Chapter 24 Cholinergic and antimuscarinic (anticholinergic) mechanisms and drugs - p. 425 39. Chapter 25 Adrenergic mechanisms and drugs - p. 436 40. Chapter 26 Cardiovascular disease and heart failure - p. 448 41. Chapter 27 Cardiac arrhythmias - p. 482 42. Chapter 28 Hyperlipidaemias - p. 496 43. Chapter 29 Kidney and genitourinary tract - p. 508 44. Chapter 30 Respiratory system - p. 526 45. Section 6 Blood and neoplastic disease - p. 542 46. Chapter 31 Drugs and haemostasis - p. 543 47. Chapter 32 Red blood cell disorders - p. 560 48. Chapter 33 Neoplastic disease and immunosuppression - p. 576 49. Section 7 Gastrointestinal system - p. 593 50. Chapter 34 Oesophagus, stomach and duodenum - p. 594 51. Chapter 35 Intestines - p. 603 52. Chapter 36 Liver and biliary tract - p. 614 53. Section 8 Endocrine system, metabolic conditions - p. 625 54. Chapter 37 Adrenal corticosteroids, antagonists, corticotropin - p. 626 55. Chapter 38 Diabetes mellitus and obesity - p. 640 56. Chapter 39 Thyroid hormones, antithyroid drugs - p. 659 57. Chapter 40 Hypothalamic, pituitary and sex hormones - p. 669 58. Chapter 41 Vitamins, calcium and bone - p. 688 59. Index - p. 704
· Additional content on practical prescribing and polypharmacy· Coverage of all major therapeutic topics by body system.· Introductory sections give brief chapter synopses.· Case studies where relevant.· Covers the needs of the developing world with a focus on practical prescribing and health technology assessment.· Definition, tips, brief explanation boxes throughout.· Interesting histories, etymologies and provenances of terms throughout.· Entertaining footnotes throughout.
Bringing in a new junior editor (a Clinical Pharmacologist) to assist as Morris Brown will not be as available as he has been in past editions.Adding in more practical prescribing information to widen the market to non-medical prescribers.Add in Polypharmacy as being added to the examsIE – Competency Mapping will be included in the IE FM for India markets (£1000 added to the manuscript development budget to cover this)
1. Clinical Pharmacology - p. c 2. Cover image - p. c 3. Quotes - p. ii 4. Title page - p. iii 5. Copyright - p. iv 6. Table of Contents - p. v 7. Preface - p. vii 8. Contributors - p. ix 9. Acknowledgements - p. xiii 10. Section 1 General - p. 1 11. Chapter 1 Clinical pharmacology - p. 2 12. Chapter 2 Topics in drug therapy - p. 5 13. Chapter 3 Discovery and development of drugs - p. 27 14. Chapter 4 Evaluation of drugs in humans - p. 36 15. Chapter 5 Health technology assessment for pharmaceutical products - p. 47 16. Chapter 6 Regulation of medicines - p. 54 17. Chapter 7 Classification and naming of drugs - p. 64 18. Chapter 8 Polypharmacy and medicines optimisation - p. 68 19. Section 2 From pharmacology to toxicology - p. 90 20. Chapter 9 General pharmacology - p. 91 21. Chapter 10 Unwanted effects and adverse drug reactions - p. 126 22. Chapter 11 Poisoning, overdose, antidotes - p. 139 23. Chapter 12 Drug dependence - p. 155 24. Section 3 Infection and inflammation - p. 180 25. Chapter 13 Chemotherapy of infections - p. 181 26. Chapter 14 Antibacterial drugs - p. 193 27. Chapter 15 Chemotherapy of bacterial infections - p. 213 28. Chapter 16 Viral, fungal, protozoal and helminthic infections - p. 236 29. Chapter 17 Therapeutics for COVID-19 - p. 266 30. Chapter 18 Drugs for inflammation and joint disease - p. 273 31. Chapter 19 Drugs and the skin - p. 296 32. Section 4 Nervous system - p. 313 33. Chapter 20 Pain and analgesics - p. 314 34. Chapter 21 Anaesthesia and neuromuscular block - p. 337 35. Chapter 22 Psychotropic drugs - p. 353 36. Chapter 23 Neurological disorders – epilepsy, Parkinson’s disease and multiple sclerosis - p. 396 37. Section 5 Cardiorespiratory and renal systems - p. 424 38. Chapter 24 Cholinergic and antimuscarinic (anticholinergic) mechanisms and drugs - p. 425 39. Chapter 25 Adrenergic mechanisms and drugs - p. 436 40. Chapter 26 Cardiovascular disease and heart failure - p. 448 41. Chapter 27 Cardiac arrhythmias - p. 482 42. Chapter 28 Hyperlipidaemias - p. 496 43. Chapter 29 Kidney and genitourinary tract - p. 508 44. Chapter 30 Respiratory system - p. 526 45. Section 6 Blood and neoplastic disease - p. 542 46. Chapter 31 Drugs and haemostasis - p. 543 47. Chapter 32 Red blood cell disorders - p. 560 48. Chapter 33 Neoplastic disease and immunosuppression - p. 576 49. Section 7 Gastrointestinal system - p. 593 50. Chapter 34 Oesophagus, stomach and duodenum - p. 594 51. Chapter 35 Intestines - p. 603 52. Chapter 36 Liver and biliary tract - p. 614 53. Section 8 Endocrine system, metabolic conditions - p. 625 54. Chapter 37 Adrenal corticosteroids, antagonists, corticotropin - p. 626 55. Chapter 38 Diabetes mellitus and obesity - p. 640 56. Chapter 39 Thyroid hormones, antithyroid drugs - p. 659 57. Chapter 40 Hypothalamic, pituitary and sex hormones - p. 669 58. Chapter 41 Vitamins, calcium and bone - p. 688 59. Index - p. 704
